Drug · DIN 02130300
HALOPERIDOL LA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 26, 2005; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02130300
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Liquid
- Route
- Intramuscular
- Therapeutic class (ATC)
- Haloperidol N05AD01
- Class
- Human
- Record last updated
- March 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HALOPERIDOL (HALOPERIDOL DECANOATE) | 100 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 25, 2005: NOC 7330New Drug Submission (NDS) · Manufacturer name change
- September 21, 1994: NOC 5698New Drug Submission (NDS)
Other DINs named HALOPERIDOL LA
- DIN 02130297 · Cancelled Post Market